Watchlist Manager

Watchlist

Price: 32.1 TWD 0.31% Market Closed

Market Cap: NT$6.1B

	Sinphar Pharmaceutical Co Ltd TWSE:1734	TW
B	Bolivar Mining Corp OTC:BOLV	CA
	Tsutsumi Jewelry Co Ltd TSE:7937	JP
	Kushim Inc TSE:2345	JP
	Riber SA PAR:ALRIB	FR

Balance Sheet

Currency: TWD

	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	119	279	275	485	234	281	399	398	424	911	517	756	1 263	917	1 095	1 070	959	841	1 144	1 195	1 238	1 074	1 076
Cash	0	0	0	0	0	0	0	0	0	843	396	462	526	450	757	657	521	588	636	770	832	714	808
Cash Equivalents	119	279	275	485	234	281	399	398	424	68	121	295	737	467	338	413	438	253	508	425	405	361	268
Short-Term Investments	35	17	34	42	32	25	55	73	15	69	87	138	64	107	45	94	17	45	50	50	7	7	102
Total Receivables	337	371	429	521	480	477	449	409	388	397	452	508	544	549	558	527	572	635	469	593	685	643	642
Accounts Receivables	232	246	304	356	352	375	361	323	297	290	338	383	378	397	403	370	436	487	352	434	506	477	495
Other Receivables	104	125	125	165	127	102	88	86	91	107	114	125	166	152	155	156	136	148	117	159	179	166	147
Inventory	241	233	275	295	367	389	379	401	420	441	518	735	862	698	612	522	488	567	681	697	737	839	715
Other Current Assets	46	50	51	49	57	57	70	55	55	41	56	97	52	50	53	45	86	174	195	168	112	85	90
Total Current Assets	777	950	1 065	1 392	1 170	1 229	1 352	1 335	1 303	1 858	1 631	2 234	2 785	2 321	2 363	2 259	2 122	2 262	2 540	2 703	2 778	2 649	2 624
PP&E Net	704	945	1 032	1 197	1 409	1 739	1 931	2 035	2 181	2 550	2 749	3 205	3 298	3 395	3 361	3 339	3 384	3 352	3 321	3 247	3 204	3 278	3 316
PP&E Gross	704	945	1 032	1 197	1 409	1 739	1 931	2 035	2 181	2 550	2 749	3 205	3 298	3 395	3 361	3 339	3 384	3 352	3 321	3 247	3 204	3 278	3 316
Accumulated Depreciation	229	276	336	381	445	505	596	701	790	924	1 049	1 202	1 366	1 513	1 628	1 779	1 930	2 062	2 246	2 424	2 627	2 796	3 032
Intangible Assets	25	25	79	73	101	89	109	79	73	45	40	40	186	335	304	261	218	190	158	117	87	72	72
Goodwill	67	53	46	47	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Note Receivable	7	0	0	0	0	0	0	0	0	0	0	47	0	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	22	25	33	11	8	7	1	0	0	18	5	87	110	238	90	103	59	30	28	20	25	22	55
Other Long-Term Assets	57	62	93	119	87	101	199	135	156	131	112	91	85	98	88	82	96	82	81	133	91	231	231
Other Assets	67	53	46	47	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	1 658 N/A	2 061 +24%	2 347 +14%	2 839 +21%	2 775 -2%	3 165 +14%	3 593 +14%	3 584 0%	3 713 +4%	4 603 +24%	4 536 -1%	5 703 +26%	6 464 +13%	6 387 -1%	6 206 -3%	6 043 -3%	5 878 -3%	5 917 +1%	6 127 +4%	6 221 +2%	6 185 -1%	6 251 +1%	6 298 +1%
Liabilities
Accounts Payable	116	106	171	173	216	171	208	206	162	167	202	291	223	207	186	157	183	212	195	201	324	291	185
Accrued Liabilities	54	56	87	101	104	126	130	144	167	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short-Term Debt	306	421	488	612	486	501	638	180	158	255	215	415	332	326	312	262	255	446	552	587	447	400	370
Current Portion of Long-Term Debt	29	161	20	21	22	34	32	110	34	388	44	51	46	77	75	82	82	81	93	61	50	51	351
Other Current Liabilities	47	58	72	42	55	69	111	117	110	287	274	463	533	412	361	351	369	417	491	685	625	463	516
Total Current Liabilities	551	801	838	950	882	900	1 120	757	630	1 098	734	1 220	1 134	1 022	934	851	889	1 156	1 330	1 535	1 446	1 205	1 423
Long-Term Debt	184	163	158	202	186	512	642	662	836	728	952	806	1 039	1 054	1 212	1 320	1 382	1 409	1 510	1 486	1 416	1 494	1 181
Minority Interest	20	120	125	141	161	161	167	144	134	150	161	486	774	742	690	552	497	420	399	355	287	300	283
Other Liabilities	28	34	34	43	43	53	57	72	87	153	159	184	212	350	279	245	184	149	143	123	107	154	148
Total Liabilities	783 N/A	1 118 +43%	1 156 +3%	1 335 +16%	1 272 -5%	1 626 +28%	1 985 +22%	1 634 -18%	1 687 +3%	2 128 +26%	2 006 -6%	2 695 +34%	3 160 +17%	3 168 +0%	3 115 -2%	2 968 -5%	2 952 -1%	3 133 +6%	3 383 +8%	3 499 +3%	3 255 -7%	3 153 -3%	3 035 -4%
Equity
Common Stock	643	675	822	979	1 058	1 058	1 069	1 183	1 277	1 493	1 493	1 493	1 613	1 613	1 677	1 677	1 677	1 677	1 677	1 677	1 677	1 677	1 811
Retained Earnings	115	132	183	240	151	175	149	243	245	270	333	551	471	353	284	295	280	276	245	211	444	634	648
Additional Paid In Capital	115	127	189	274	271	269	324	447	480	712	719	962	1 200	1 200	1 157	1 132	1 046	959	941	964	930	924	924
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	0	0	0	4	7	50	23	29	14	31	33	37	41	44	50
Other Equity	3	9	3	11	23	37	66	78	26	0	15	6	28	4	50	58	63	98	86	92	81	93	70
Total Equity	875 N/A	943 +8%	1 191 +26%	1 504 +26%	1 503 0%	1 539 +2%	1 608 +5%	1 950 +21%	2 027 +4%	2 475 +22%	2 530 +2%	3 008 +19%	3 304 +10%	3 219 -3%	3 092 -4%	3 075 -1%	2 926 -5%	2 783 -5%	2 744 -1%	2 722 -1%	2 930 +8%	3 098 +6%	3 263 +5%
Total Liabilities & Equity	1 658 N/A	2 061 +24%	2 347 +14%	2 839 +21%	2 775 -2%	3 165 +14%	3 593 +14%	3 584 0%	3 713 +4%	4 603 +24%	4 536 -1%	5 703 +26%	6 464 +13%	6 387 -1%	6 206 -3%	6 043 -3%	5 878 -3%	5 917 +1%	6 127 +4%	6 221 +2%	6 185 -1%	6 251 +1%	6 298 +1%
Shares Outstanding
Common Shares Outstanding	108	113	129	142	142	142	144	154	166	190	190	190	190	190	190	190	190	190	190	190	190	190	190

Income Statement Balance Sheet Cash Flow Statement

Sinphar Pharmaceutical Co Ltd
TWSE:1734

Balance Sheet

Balance Sheet Decomposition
Sinphar Pharmaceutical Co Ltd

Balance Sheet
Sinphar Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Sinphar Pharmaceutical Co Ltd TWSE:1734

Balance Sheet

Balance Sheet Decomposition Sinphar Pharmaceutical Co Ltd

Balance Sheet Sinphar Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Sinphar Pharmaceutical Co Ltd
TWSE:1734

Balance Sheet Decomposition
Sinphar Pharmaceutical Co Ltd

Balance Sheet
Sinphar Pharmaceutical Co Ltd